Schrodinger Inc Equity-NMS: SDGR

Healthcare

Health Information Services

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$28.55

52W high :

$66.49

1Y :

-47.91%

5Y :

-8.6%

EPS(TTM): :

-2.08

Shares O/S :

62.03 M

Market cap :

1.74 B

What is the share price of Schrodinger Inc today?

Schrodinger Inc (SDGR) share price as of August 19, 2022, is $0. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Schrodinger Inc?

Yes, Indian Investors can invest in the Schrodinger Inc (SDGR) Share by opening an international trading account with Angel One.

How can I purchase Schrodinger Inc shares in India?

Purchasing Schrodinger Inc (SDGR) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Schrodinger Inc (SDGR) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Schrodinger Inc?

Yes, you can purchase fractional shares of Schrodinger Inc (SDGR) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Schrodinger Inc?

The market capitalization of Schrodinger Inc on August 19, 2022, is $1.72 B.

In which sector Schrodinger Inc belongs?

Schrodinger Inc operates in the Healthcare sector, specifically in the Health Information Services industry.

What documents are required to invest in Schrodinger Inc stocks?

In order to invest in Schrodinger Inc (SDGR) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Schrodinger, Inc. has developed a physics-based software platform, which enables discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions and government laboratories around the world. The Company also leverages its software platform to advance collaborative programs and its own pipeline of therapeutics to address unmet medical needs. The Company operates through two segments: software and drug discovery. The software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on building a portfolio of preclinical and clinical programs, internally and through collaborations, which has advanced to various stages of discovery and development. The Company’s pipeline of drug discovery programs include MALT1, CDC7, Wee1, and SOS1/KRAS.